Fully synthetic self-adjuvanting MUC1-fibroblast stimulating lipopeptide 1 conjugates as potential cancer vaccines
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fully synthetic self-adjuvanting MUC1-fibroblast stimulating lipopeptide 1 conjugates as potential cancer vaccines
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 52, Issue 72, Pages 10886-10889
Publisher
Royal Society of Chemistry (RSC)
Online
2016-08-04
DOI
10.1039/c6cc04623a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic Cancer
- (2016) Björn Palitzsch et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment
- (2016) Nuria Martínez-Sáez et al. Chemical Science
- Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide
- (2015) Pamela Thompson et al. CHEMICAL COMMUNICATIONS
- A fully synthetic self-adjuvanting globo H-Based vaccine elicited strong T cell-mediated antitumor immunity
- (2015) Zhifang Zhou et al. Chemical Science
- A Cancer Therapeutic Vaccine based on Clustered Tn-Antigen Mimetics Induces Strong Antibody-Mediated Protective Immunity
- (2014) Barbara Richichi et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
- (2014) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Fully Synthetic Four-Component Antitumor Vaccine Consisting of a Mucin Glycopeptide Antigen Combined with Three Different T-Helper-Cell Epitopes
- (2014) Björn Palitzsch et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates
- (2014) David M. McDonald et al. CHEMICAL COMMUNICATIONS
- Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers
- (2014) Zhifang Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- CpG-Loaded Multifunctional Cationic Nanohydrogel Particles as Self-Adjuvanting Glycopeptide Antitumor Vaccines
- (2014) Sebastian Hartmann et al. Advanced Healthcare Materials
- Water-Soluble Polymers Coupled with Glycopeptide Antigens and T-Cell Epitopes as Potential Antitumor Vaccines
- (2013) Lutz Nuhn et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Self-Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T-Cell Epitopes from Tetanus Toxoid
- (2013) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The development of synthetic antitumour vaccines from mucin glycopeptide antigens
- (2013) Nikola Gaidzik et al. CHEMICAL SOCIETY REVIEWS
- Synthetically defined glycoprotein vaccines: current status and future directions
- (2013) Roberto Adamo et al. Chemical Science
- Variation of the Glycosylation Pattern in MUC1 Glycopeptide BSA Vaccines and Its Influence on the Immune Response
- (2012) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tobacco Mosaic Virus as a New Carrier for Tumor Associated Carbohydrate Antigens
- (2012) Zhaojun Yin et al. BIOCONJUGATE CHEMISTRY
- a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
- (2012) Zhi-Hua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
- (2011) Brendan L. Wilkinson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthetic Antitumor Vaccines Containing MUC1 Glycopeptides with Two Immunodominant Domains-Induction of a Strong Immune Response against Breast Tumor Tissues
- (2011) Nikola Gaidzik et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In vivo anti- and pro-tumour activities of the TLR2 ligand FSL-1
- (2011) Kazuto Kiura et al. IMMUNOBIOLOGY
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
- (2010) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
- (2010) Mariusz Skwarczynski et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis of MUC1–lipopeptide chimeras
- (2010) Brendan L. Wilkinson et al. CHEMICAL COMMUNICATIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now